(113 Results)
Filter
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Filling the gaps in asthma careTraining the immune system with microbial products ...
-
Relegating OCS to last resort: Creating a paradigm shift in asthma managementAstraZeneca: Relegating OCS to last resort: Creating a paradigm shift in asthma management...
-
Severe type 2 asthma: phenotypes and precision treatment for patientsOpening remarks ...
-
Strengthening the immune system to reduce asthma risk: paving the way to the future?Welcome & Introduction ...
-
IgE in asthma and nasal polyposis: your questions answered
-
TSLP: a key epithelial cytokine at the top of the asthma inflammatory cascadeIoana Agache, Andrew Menzies-gow, Stephanie Korn, Celeste Porsbjerg
-
Targeted therapy for patients with severe eosinophilic asthma – an interactive conversation with experts
-
A unified approach: Improving patient outcomes in severe asthma and comorbid eosinophilic diseasesWelcome and introduction ...
-
Can we break the cycle of lung function decline and asthma exacerbations driven by type 2 inflammation in asthma?Guy Brusselle, Klaus F. Rabe This Company Sponsored Sy...
-
Breaking new ground: A closer look at Type 2 Inflammation in pediatric asthma
-
Managing severe asthma and CRSwNP: Through the lens of Type 2 InflammationOpening remarks ...
-
Championing change: Is elimination of oral corticosteroid use in asthma achievable today?
-
Asthma, does allergy matter?Welcome and introduction/1 ...
-
Childhood Asthma and the Impact of Type 2 InflammationOpening Remarks ...
Show more Sponsored Symposia (12)Show Less-
-
Elderly asthma
-
Viral infection and asthma
-
Bronchiectasis and severe asthma
-
Immunotherapy in severe asthma (AIT)
-
Late onset T2 asthma – a case study
-
Updates in [severe] asthma in adults
-
Tezepelumab (anti-TSLP) in asthma
-
Targeted approaches for asthma
-
The basics of severe asthma - biomarkers
-
Difficult to control asthma in children
-
Difficult to control asthma in adults
-
Exercise: induced asthma and rhinitis
-
Big changes in asthma treatment : GINA 2019
-
Focus on Patient. Personalised therapy for severe asthma
-
Implementation of telehealth in asthma management: trials and tribulations
-
Benralizumab in severe eosinophilic asthma… Or is it something else?
-
Allergic severe asthma and cat epithelia in COVID-19 pandemic: a case report
-
Alternaria-induced thunderstorm asthma: An unrecognised trigger
-
Biological severe asthma treatment in Poland - pros and cons of drug programme
-
Early life wheeze - risk factors for asthma in school age
-
A system biology and machine learning approach to childhood asthma
-
Impact of climate change on asthma exacerbations
-
Efficacy and safety of masitinib in severe asthma: Eosinophilic subgroup analysis from study AB07015
-
The role of EGR-1 as a potential biomarker in asthma and proinflammatory responses in airway epithelium
-
Moderate-to-severe asthma in individuals of European ancestry: a genome-wide association study
-
NEK7-NLRP3 binding is essential in the assembly of NLRP3 inflammasome in the pathogenesis of house dust mite-induced asthma
-
How to select and follow a biological for asthma and CRSwNP
-
Diagnosis and allocation to biologics in severe asthma – guidelines of the Polish Society of Allergology
-
Age-related changes in innate immune response to in vitro rhinovirus infection in asthma patients
-
Bacterial lysates in asthma treatment in children / Lizaty bakteryjne w astmie u dzieci.
-
Mechanisms of airway remodeling unique to eosinophilic asthma: Insights from differential gene co-expression analysis
-
Time for innovation: what can we learn from OMICs about asthma metabolic dysfunction?
-
Opportunities and Obstacles to treat severe asthma with new biologics based on experiences from real world practice
-
Real-world clinical outcomes for patients in the UK with severe, atopic eosinophilic asthma treated with benralizumab
-
Does pediatric asthma primarily depend on submicrone aerosol pollutants?
-
Biologicals in allergy and asthma: A deep learning approach to optimized patient management
-
Pediatric Asthma in Real Life (PeARL): addressing controversies in pediatric asthma
-
Stratification of asthma phenotypes by airway proteomic signatures: A system biology approach
-
The effect of tezepelumab in patients with allergic asthma: Results from the PATHWAY phase IIb study
-
The effect of tezepelumab in patients with allergic and non-allergic asthma: results from the NAVIGATOR phase 3 study
-
Development of a childhood asthma prediction model using machine learning approaches
-
Dupilumab and live-attenuated vaccines: experience with prior dupilumab use and yellow fever vaccine in patients with severe asthma from Brazil
-
The α2β1 integrin, a collagen-binding receptor, may be involved in pathology of airway remodelling in asthma
-
Seasonal variability of exacerbations in patients with severe, uncontrolled asthma and clinical benefits of tezepelumab: Results from the PATHWAY phase 2b study
-
The clinical case of the great dupilumab efficacy in the treatment of the severe asthma comorbid with chronic rhinosinusitis with nasal polyps
-
What are the best end-points in AIT asthma trials - the clinician point of view?
-
Benralizumab efficacy for severe, eosinophilic asthma with a diagnosis of nasal polyposis: Results from the phase IIIb ANDHI trial
-
Why is a transition clinic needed for adolescents and young adults (AYA) with allergy and asthma?
-
Dupilumab associated with lower reports of respiratory infections in moderate-to-severe asthma - safety analysis from the LIBERTY ASTHMA QUEST study
-
Dupilumab reduces severe exacerbations in patients with uncontrolled, moderate-to-severe allergic (atopic) asthma regardless of presence of perennial aeroallergen-specific IgE: LIBERTY ASTHMA QUEST
-
Healthcare use and asthma control among overweight/obese urban children sensitized and exposed to classroom allergens
-
A post hoc analysis of dupilumab efficacy in asthma patients with comorbid allergic rhinitis and chronic rhinosinusitis/nasal polyps from the LIBERTY ASTHMA QUEST study
-
COVID-19 and virus-induced asthma in children: Asian vs western perspectives
-
Effects of tezepelumab on asthma exacerbations, type 2 biomarkers, lung function and asthma control in patients with severe, uncontrolled asthma with and without nasal polyps: PATHWAY phase IIb study
-
FeNO, forced oscillation, or spirometry? Lung function testing in wheezy pre-schoolers and the prediction of asthma, a systematic review
-
Assessment of efficacy of allergen immunotherapy in patients with allergic rhinitis and atopic asthma
-
The impact of the exposome on allergies and asthma – a global view on urbanisation, climate change and pollution
-
Dupilumab improves asthma control and health-related quality of life in children with uncontrolled persistent asthma: VOYAGE study
-
Efficacy of dupilumab in children with uncontrolled, moderate-to-severe type 2 asthma, with/without evidence of allergic asthma: the VOYAGE phase 3 study
-
Impact of omalizumab on severe food allergy in 54 italian patients with concomitant asthma: 6-year-long experience
-
House dust mite allergen-specific immunotherapy using an adjuvant- and allergoid-based approach in a murine model of allergic asthma
-
Severe Asthma and COVID-19
-
Electronic Health in Severe Asthma
-
Asthma: phenotypes to endotypes
-
EAACI Biologicals Guidelines – Recommendations for Severe Asthma
-
Asthma management during the COVID-19 pandemics
-
Beyond first line therapies for recalcitrant allergic diseases: Asthma
-
Asthma endotypes as risk factors for severe COVID-19 manifestations
-
Three-year follow-up of the 2016 Melbourne Epidemic Thunderstorm Asthma patients: Insight into symptoms, healthcare seeking, and medication compliance
Show more Event Resources (67)Show Less-
-
DGAKI statement on asthma and COVID-19AIT and COVID-19 March 18, 2020 Dear colleagues, In the past few days, we have received mo...
-
Shielding against SARS-CoV-2 infections is not justified in children with severe asthma For the EU‐funded project PERMEABLE (PERsonalized MEdicine Approach for asthma and aller...
-
Severe asthma in adults does not significantly affect the outcome of COVID‐19 disease: results from the Italian Severe Asthma RegistryDespite the clinical burden of severe asthma is substantial, there is evidence of a neutra...
-
Real‐life impact of COVID‐19 pandemic lockdown on the management of pediatric and adult asthma: a survey by the EAACI Asthma SectionAbstract Background The restrictions imposed by the COVID-19 pandemic impact heavily the m...
-
Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohortThe PeARL multinational cohort included 1,054 children with asthma and 505 non‐asthmatic...
-
Position statement of expert panel of the Polish Allergology Society (PTA) on the management of patients with bronchial asthma and allergic diseases during the SARS-CoV-2 pandemicThe dynamically changing epidemiological situation related to SARS-CoV-2 infection poses c...
-
Characterization of asthma and risk factors for delayed SARS‐CoV‐2 clearance in adult COVID‐19 inpatients in DaeguIn summary, despite the differences depending on phenotypes, the prevalence of asthma was ...
-
Association of endopeptidases, involved in SARS‐CoV‐2 infection, with microbial aggravation in sputum of severe asthmaHigh expression of such endopeptidases may be associated not only with a higher risk of SA...
-
Association between asthma and clinical mortality/morbidity in COVID‐19 patients using clinical epidemiologic data from Korean Disease Control & PreventionCoronavirus disease 2019 (COVID‐19) has rapidly spread worldwide, posing a serious publi...
-
Association of Respiratory Allergy, Asthma and Expression of the SARS-CoV-2 Receptor, ACE2Asthma and respiratory allergies have not been identified as risk factor for severe Covid-...
-
Asthma control, self‐management and healthcare access during the COVID‐19 epidemic in BeijingThe results support the recommendation that patients continue taking their prescribed asth...
-
COVID‐19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatmentsIn conclusion, in our large cohort of severe asthmatics, only a small minority experienced...
Show more Covid-19 (10)Show Less-
-
Immunometabolism in allergy and asthma – AllerIMMETThe epidemics of chronic inflammatory disorders of the upper and lower airways, as well as...
-
Public outreach for immunological mechanisms in allergies and asthmaIn Europe, approximately 150 million citizens suffer from chronic allergic diseases and 7 ...
-
Systematic biobanking for precision medicine in asthma and allergic diseasesPrecision medicine is an emerging field gaining high interest due to the limitations of st...
-
Principles for targeting eicosanoids in the treatment of asthma and allergic diseasesEicosanoids are a family of fatty acid metabolites that includes prostaglandins, leukotrie...
-
Work-related asthma questionnaires and algorithms for screening and surveillance (WAQASS)Work-related exposures contribute up to one third of adult asthma, causing occupational as...
-
Asthma prevalence management in pregnancyAsthma is among the commonest chronic diseases during young adulthood, which determines a ...
Show more Task Forces (4)Show Less-
Website
Collapse
-
Iran - Iranian Society of Asthma and Allergy
-
Turkey - Academy of Pediatric Allergy and Asthma (CAAAD)
-
Saudi Arabia - Saudi Allergy Asthma & Immunology Society (SAAIS)
-
Cuba - Cuban Society of Allergy, Asthma and Clinical Immunology (CSAACI)
-
Korea - Korean Academy of Asthma, Allergy, and Clinical Immunology (KAAACI)
-
Albania - Albanian Society of Allergy, Asthma and Clinical Immunology (ASAACI)
-
Spain - Spanish Pediatric Society of Clinical Immunology, Allergy and Asthma (SEICAP)
-
Asia Pacific - Asia Pacific Association of Allergy Asthma and Clinical Immunology (APAAACI)
Show more Member societies (6)Show Less-
-
Launch of the PAI Virtual Issue on Asthma & EnvironmentIn an effort to further elucidate the environmental factors that are central to our unders...
-
Take the EAACI Survey: Exercise and Physical Activity for Asthma ManagementThe European Academy of Allergy and Clinical Immunology (EAACI) have designed a short onli...
-